leucine rich alpha-2-glycoprotein 1
| GO Term | Evidence Code | PMID |
|---|---|---|
| positive regulation of endothelial cell proliferation | ||
| immune response | ||
| transforming growth factor beta receptor signaling pathway | ||
| response to bacterium | ||
| positive regulation of epithelial to mesenchymal transition |
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region | ||
| extracellular region | ||
| extracellular region | ||
| extracellular space | ||
| extracellular space |
| GO Term | Evidence Code | PMID |
|---|---|---|
| type II transforming growth factor beta receptor binding | ||
| protein binding | ||
| type I transforming growth factor beta receptor binding | ||
| transforming growth factor beta binding |
| InterPro |
|---|
| Leucine-rich repeat domain superfamily |
| Leucine-rich repeat, typical subtype |
| Leucine-rich repeat |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026